L-Thyroxine suppressive therapy and autonomic nervous system control in patients with thyroid disease.
Lelio
L
Morricone
Alexis Elias
AE
Malavazos
Emanuele
E
Cereda
Cristina
C
Donati
Bruno
B
Ambrosi
D001341:Autonomic Nervous System / Q000503:physiopathology*; D003371:Cough / Q000503:physiopathology; D004305:Dose-Response Relationship, Drug; D005260:Female; D006044:Goiter, Nodular / Q000188:drug therapy / Q000503:physiopathology; D006339:Heart Rate / Q000187:drug effects / Q000502:physiology; D006801:Humans; D006980:Hyperthyroidism / Q000503:physiopathology; D007022:Hypotension / Q000503:physiopathology; D008297:Male; D008451:Maximal Voluntary Ventilation / Q000502:physiology; D008875:Middle Aged; D011187:Posture / Q000502:physiology; D013959:Thyroid Diseases / Q000188:drug therapy* / Q000503:physiopathology*; D013974:Thyroxine / Q000494:pharmacology / Q000627:therapeutic use*; D014630:Vagus Nerve / Q000503:physiopathology
D013974:Thyroxine